ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,394, issued on Jan. 27, was assigned to GLYCOMANTRA INC. (Baltimore).
"Compositions and methods for treating metabolic disorders" was invented by Hafiz Ahmed (Leesburg, Va.) and Khairul Anam (Gaithersburg, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a metabolic disorder includes identifying a subject having a metabolic disorder and administering to the subject a therapeutically effective amount of GM201, wherein the therapeutically effective amount is between 0.1 mg/kg and 500 mg/kg with respect to a body weight of the subject."
The patent was filed on Oct. 28, 2024, under Application No. 18/929,081.
*For further inform...